What's new in atopic eczema? An analysis of systematic reviews published in 2016. Part 1: treatment and prevention

Abstract

Summary This review is part of a series of annual updates summarizing the evidence base for atopic eczema (AE). It provides a summary of key findings from 28 systematic reviews that were published or indexed during 2016 with a focus on treatment and prevention of AE. There is reasonable evidence of benefit for topical corticosteroids, calcineurin inhibitors, a glycyrrhetinic acid‐containing preparation (Atopiclair®), oral ciclosporin, oral azathioprine, narrowband ultraviolet B radiation and education programmes. Overall, there is evidence that topical corticosteroids and calcineurin inhibitors have similar efficacy and that both can prevent AE flares when used twice weekly as maintenance therapy. However, topical calcineurin inhibitors are costlier and have more adverse reactions, thus topical corticosteroids should remain the standard of care for patients with AE. There is no evidence that multiple applications are better than once‐daily application of topical corticosteroid. There is inconsistent evidence to support omalizumab and specific allergen immunotherapy use in AE. There is some evidence that vitamin D supplementation and synbiotics reduce AE severity, although the margin of improvement may not be clinically meaningful. There is little evidence to support the use of wet wraps or of complementary/alternative medicine (including Chinese herbal medicine). There is some evidence to suggest that a diet high in fish in infancy may be preventative for AE, but other dietary interventions for the prevention of AE show little promise. This review provides a succinct guide for clinicians and patients wishing to remain up to date with the latest evidence for the treatment and prevention of AE.

Systematic review about 10 interventions in dermatitis. A document from the Latin American Society of Allergy, Asthma, and Immunology

“…20,41 Findings from 14 systematic reviews published before 2016 observed that persistent atopic dermatitis is associated with more severe disease at the time of diagnosis, onset after the age of two years and being a female. 42 A systematic review in- cluding 45 studies was considered and found that a later onset increased persistence. 43 Some genetic factors have been associated with persistent dermatitis, but these factors are not easy to use in clinical practice.…”

Assessment of the Effectiveness of Vitamin Supplement in Treating Eczema: A Systematic Review and Meta-Analysis

“…Presently, through a set of systematic remedies ranging from emollients to corticosteroids, we are able to manage most of the symptoms of eczema [23]. Although the exact etiology of eczema is still unknown, a combination of genetic and environmental factors is involved.…”

‘Tis but a scratch: discussing the future of eczema treatment in the wake of a psoriasis revolution

“…10 Topical calcineurin inhibitors can improve mild to moderate eczema without the same side effects as steroids. 11 However, this medication is not subsidised by PHARMAC. 12 If these medications are not effective, some oral medications are approved for eczema.…”

“…7,13 The most promising sign of this change is the research effort around new eczema treatments. Solman et al 11 periodically publish a review of the literature around eczema treatments and noted that each year more and more systematic reviews are published on novel treatments and new regimes. Each biologic medication like dupilumab that has found success is one of hundreds of medications devised and tested by pharmaceutical companies.…”